A2BP1 anticorps (N-Term)
Aperçu rapide pour A2BP1 anticorps (N-Term) (ABIN927946)
Antigène
Voir toutes A2BP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- A2 BP1 antibody was raised in rabbit using the N terminal of A2 P1 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
A2BP1 Blocking Peptide, (ABIN5611836), is also available for use as a blocking control in assays to test for specificity of this A2BP1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- A2BP1 (Ataxin 2-Binding Protein 1 (A2BP1))
-
Autre désignation
- A2BP1
-
Sujet
- Ataxin-2 binding protein 1(A2BP1) has an RNP motif that is highly conserved among RNA-binding proteins. This protein binds to the C-terminus of ataxin-2 and may contribute to the restricted pathology of spinocerebellar ataxia type 2 (SCA2). Ataxin-2 is the gene product of the SCA2 gene which causes familial neurodegenerative diseases. Ataxin-2 binding protein 1 and ataxin-2 are both localized in the trans-Golgi network. Synonyms: Polyclonal A2BP1 antibody, Anti-A2BP1 antibody, ataxin 2-binding protein 1 antibody, FOX1 antibody, HRNBP1 antibody.
Antigène
-